What is happening in the pharmaceutical market?
On September 21-22, 2009 infor-media Russia will hold a special autumn session of pharmaceutical business leaders.
What is happening in the pharmaceutical market? It is this issue that will form the basis of discussion at the conference.
Among the main topics:How do the top officials of the industry see the consequences of the crisis for the development of their companies
- Financial condition of the industry: myths and reality
- Potential of the Russian market of mergers and acquisitions in the pharmaceutical business
- Manufacturer — distributor — retail: Who benefited from the crisis? Who has become stronger?
- Analysis of the redistribution of market shares. Blockbusters 2009. Assortment strategies in pharmaceuticals
Special emphasis: Special panel discussion on "Antimonopoly regulation in the pharmaceutical business"
- Case-study of foreign and Russian pharmaceutical companies with new approaches and solutions to overcome the recession
Who is participating?200+ representatives of Russian and international pharmaceutical companies
- Job description: top managers and managers
- All players of the pharmaceutical market: manufacturers, pharmacy chains, distributors
- Representatives of regulators and authorities
2 official languages of the conference: Russian and English
Among the participants of our previous conferences are representatives of such companies as: Pharmacy Chain 36,6, AstraZeneca, Pharmacy-Holding, Akrikhin, Bolear, Boston Consulting Group, Bristol-Myers Squibb, Baker & Mackenzie, Valenta, Verwag Pharma", "Gideon Richter", Dr. Reddy's Laboratories LTD, "Johnson & Johnson", "Doctor Stoletov", "Implosion", "Intermedservice", "IPSEN", "Ingosstrakh", "QUATRAIN", "Boiron Laboratory", "Mosoblfarmation", "Novartis Pharma", Novo Nordisk, First Aid, Petrovax FC, POLISAN, PricewaterhouseCoopers, Pfizer, Raiffeisenbank, Rigla, Peptek, Polish Medicines, Pliva Rus, Rasha Partners Management L.L.S., Rosta, "Roche-Moscow", "Sanofi-Aventis", "Servier Russia", "Solway Pharma", "Pharmexpert", "Pharmstandard", "Pharmsintez", "Sharing", CV "PROTEK", "Zambon Spa", "Abbott Laboratories", "Janssen Pharmaceuticals NV.", ABN Amro, BASF, Cegedim Dendrite Russia, DSM Group, Eli Lilly, J.P.Morgan, KRKA, Marshall Capital, Nycomed, Pharmadule AB, Pepeliaev, Goltsblat & Partners, RMBC, Ratiopharm RUS, Strategy Partners, Solvay Pharma, Tamro Corporation, Teva Pharmaceutical and many others.
The details are here.
Portal "Eternal youth" http://vechnayamolodost.ru/19.06.2009